Vibramycin IV
- Generic Name: doxycycline hyclate
- Brand Name: Vibramycin Intravenous
Vibramycin Intravenous (Doxycycline hyclate) side effects drug center
- Related Drugs
- Health Resources
- Related Supplements
- stomach upset
- loss of appetite
- diarrhea
- nausea
- vomiting
- skin rash
- itching
- headache
- vaginal itching or discharge, or
- rectal discomfort.
What Is Vibramycin IV?
Vibramycin I.V. (doxycycline hyclate) is a tetracycline antibiotic used to treat many different bacterial infections such as urinary tract infections acne gonorrhea and chlamydia periodontitis (gum disease) and others. The brand name Vibramycin I.V. has been discontinued in the U.S. Generic versions may be available.
What Are Side Effects of Vibramycin IV?
Common side effects of Vibramycin I.V. (doxycycline hyclate) include:
Tell your doctor if you have serious side effects of Vibramycin I.V. (doxycycline hyclate) including sunburn-like skin reaction (sun sensitivity), an unusual change in the amount of urine, unusual tiredness, injection site reactions (redness/swelling/pain), weakness, hearing changes (ringing in the ears, decreased hearing), easy bruising or bleeding, new signs of infection (persistent sore throat, fever, chills), stomach or abdominal pain, or persistent nausea or vomiting.
Additional Information
Our Vibramycin (doxycycline hyclate) for Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor right away if you have serious side effects such as: sunburn-like skin reaction (sun sensitivity), unusual change in the amount of urine, unusual tiredness, redness/swelling/pain at the injection site, weakness, hearing changes (e.g., ringing in the ears, decreased hearing), easy bruising/bleeding, new signs of infection (e.g., persistent sore throat, fever, chills), stomach/abdominal pain, persistent nausea/vomiting.
Tetracycline drugs such as doxycycline may rarely cause a serious increase in pressure inside the skull (intracranial hypertension-IH). The risk of this side effect is greater for women of childbearing age who are overweight or who have had IH in the past. If IH develops, it usually goes away after doxycycline is stopped; however, there is a chance of permanent vision loss or blindness. Get medical help right away if you have: persistent/severe headache, vision changes (such as blurred/double vision, decreased vision, sudden blindness), persistent nausea/vomiting.
This medication may rarely cause a severe intestinal condition (Clostridium difficile-associated diarrhea) due to a type of resistant bacteria. This condition may occur during treatment or weeks to months after treatment has stopped. Do not use anti-diarrhea products or narcotic pain medications if you have any of the following symptoms because these products may make them worse. Tell your doctor immediately if you develop: persistent diarrhea, abdominal or stomach pain/cramping, blood/mucus in your stool.
Use of this medication for prolonged or repeated periods may result in oral thrush or a new vaginal yeast infection. Contact your doctor if you notice white patches in your mouth, a change in vaginal discharge, or other new symptoms.
A very serious allergic reaction to this drug is rare. However, get medical help right away. if you notice any of the following symptoms of a serious allergic reaction, including: rash, skin sores/blisters, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing, new or worsening swelling/pain in the joints, chest pain, fast/irregular heartbeat.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Vibramycin IV (Doxycycline hyclate)
SIDE EFFECTS
Gastrointestinal: anorexia, nausea, vomiting, diarrhea, glossitis, dysphagia, enterocolitis, inflammatory lesions (with monilial overgrowth) in the anogenital region, and pancreatitis. Hepatotoxicity has been reported rarely. These reactions have been caused by both the oral and parenteral administration of tetracyclines. Superficial discoloration of the adult permanent dentition, reversible upon drug discontinuation and professional dental cleaning has been reported. Permanent tooth discoloration and enamel hypoplasia may occur with drugs of the tetracycline class when used during tooth development. (See WARNINGS)
Skin: maculopapular and erythematous rashes. Exfoliative dermatitis has been reported but is uncommon. Photosensitivity is discussed above. (See WARNINGS)
Renal toxicity: Rise in BUN has been reported and is apparently dose related. (See WARNINGS)
Immune: Hypersensitivity reactions including urticaria, angioneurotic edema, anaphylaxis, anaphylactoid purpura, pericarditis, exacerbation of systemic lupus erythematosus, and drug reaction with eosinophilia and systemic symptoms (DRESS).
Other: Bulging fontanels in infants and intracranial hypertension in adults. (See WARNINGS)
Blood: Hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia have been reported.
When given over prolonged periods, tetracyclines have been reported to produce brown-black microscopic discoloration of thyroid glands. No abnormalities of thyroid function studies are known to occur.
Read the entire FDA prescribing information for Vibramycin IV (Doxycycline hyclate)
© Vibramycin IV Patient Information is supplied by Cerner Multum, Inc. and Vibramycin IV Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.